Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, <em class="a-plus-plus">i.e.</em>, increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and <em class="a-plus-plus">ex vivo</em> molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes.</p>

Molecular network strategy in multi-omics and mass spectrometry imaging

iMS2Net: A multiscale networking methodology to decipher metabolic synergy of organism

Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach

Development of Multiomics in Situ Pairwise Sequencing (Mip-Seq) for Single-cell Resolution Multidimensional Spatial Omics

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

New perspective on central nervous system disorders: focus on mass spectrometry imaging

Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data

A Survey on Computational Approaches to Identifying Disease Biomarkers Based on Molecular Networks.

Applications of multi‐omics analysis in human diseases

Network Topology Evaluation and Transitive Alignments for Molecular Networking

Inferring Interaction Networks from Multi-Omics Data.

Dissecting the Brain with Spatially Resolved Multi-Omics

Spatially resolved metabolomics: From metabolite mapping to function visualising

Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy

Network-based strategies in metabolomics data analysis and interpretation: from molecular networking to biological interpretation

Multi‐modal mass spectrometry imaging of a single tissue section

Mass Spectrometry-Based Omics and Imaging Technique: A Novel Tool for Molecular Toxicology and Health Impacts

Divide and Conquer: A Flexible Deep Learning Strategy for Exploring Metabolic Heterogeneity from Mass Spectrometry Imaging Data

Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications

High spatial resolution mass spectrometry imaging for spatial metabolomics: Advances, challenges, and future perspectives